Impact of Albumin on Survival in Critically Ill Patients
Author Information
Author(s): Vincent Jean-Louis, Sakr Yasser, Reinhart Konrad, Sprung Charles L, Gerlach Herwig, Ranieri V Marco
Primary Institution: Erasme Hospital, Free University of Brussels
Hypothesis
Is albumin administration in the acutely ill associated with increased mortality?
Conclusion
Albumin administration was associated with decreased survival in this population of acutely ill patients.
Supporting Evidence
- Patients who received albumin had a higher ICU mortality rate (35% vs 16%).
- In matched pairs, ICU mortality rates were higher in patients who received albumin (34.8% vs 20.9%).
- The study included 3,147 patients across multiple European ICUs.
Takeaway
Giving albumin to very sick patients might make them less likely to survive. It's like giving a special drink to someone who is already very sick, and it doesn't help them get better.
Methodology
This was a multicenter, observational study following patients admitted to ICUs over a two-week period, comparing those who received albumin to those who did not.
Potential Biases
Potential confounding factors were not fully accounted for, and the observational nature of the study may introduce bias.
Limitations
The study did not record the indications for albumin administration or measure serum albumin levels.
Participant Demographics
Patients included were older than 15 years, with a mix of surgical and medical admissions, and a higher prevalence of cancer and liver cirrhosis among those receiving albumin.
Statistical Information
P-Value
0.012
Confidence Interval
1.11–2.22
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website